Literature DB >> 1376194

Pathology of carcinoma of the prostate.

F K Mostofi1, C J Davis, I A Sesterhenn.   

Abstract

In this presentation the authors review the pathology of prostatic carcinoma (PCa), and discuss criteria for pathologic diagnosis, premalignant lesions, lesions that simulate PCa, immunopathology, special types of PCa, effects of therapy on the prostate, and recent efforts to improve diagnostic and prognostic capabilities. The possible role of study of nucleolar organizing regions is reported. A new method for demonstration of chromosome in formalin-fixed, paraffin-embedded tissue is presented. The need for research in all aspects of pathology is emphasized.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376194     DOI: 10.1002/1097-0142(19920701)70:1+<235::aid-cncr2820701311>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Incidental prostatic carcinoma. A predictive role of neoangiogenesis and comparison with other prognostic factors.

Authors:  M Volavsek; A Masera; Z Ovcak
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  Serum TPS, PSA, and PAP values in relapsing stage D2 adenocarcinoma of the prostate.

Authors:  I Kraljić; K Kovacić; M Tarle
Journal:  Urol Res       Date:  1994

3.  A reliable biomarker derived from plasmalogens to evaluate malignancy and metastatic capacity of human cancers.

Authors:  Rosina E Smith; Pablo Lespi; María Di Luca; Claudia Bustos; Fernando A Marra; María J T de Alaniz; Carlos A Marra
Journal:  Lipids       Date:  2007-11-29       Impact factor: 1.880

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.